title: Evaluation of Ki67, p16 and CK17 Markers in Differentiating Cervical Intraepithelial Neoplasia and Benign Lesions.
abstract: BACKGROUND
  Cervical intraepithelial neoplasia (CIN) is a premalignant lesion capable of progressing to cervical cancer. Despite the existing well-defined criteria, the histomorphologic diagnosis is subject to high rates of discordance among pathologists. The aim of this study was to evaluate Ki-67 (MIB-1), CK17 and p16 (INK4a) (p16) markers by immunohistochemical methods in differentiating CIN from benign cervical lesions.
  
  
  METHODS
  The present study reviewed and re-classified 77 cervical biopsies, originally diagnosed as 31 non-CIN, and 46 CIN, as 54 non-CIN, and 23 CIN based on at least two similar diagnoses. Immunostaining by Ki67, p16 and CK17 markers was performed on all cases and the results were compared with pervious and consensus diagnosis.
  
  
  RESULTS
  The overall agreement between pervious and consensus diagnosis was 67.5% (Kappa=0.39, P<0.001). The sensitivity and specificity of Ki67 immunostaining were 95.6% and 85.1% respectively, while for p16 the corresponding values were 91.3% and 98.1%. The overall agreement, for both p16 and Ki67, with consensus diagnosis were significant (P<0.001). The sensitivity and specificity of CK17 negative staining in CIN detection were 39.1% and 40.7% respectively.
  
  
  CONCLUSIONS
  Ki67 and p16 markers are recommended as complementary tests for differentiating between dysplastic and non-dysplastic lesions. CK17 does not discriminate between immature metaplasia with and without dysplasia.
authors: Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran;
authors: Fatemeh
authors: F
authors: Sari Aslani
authors: Akbar
authors: A
authors: Safaei
authors: Masoumeh
authors: M
authors: Pourjabali
authors: Mozhdeh
authors: M
authors: Momtahan
keywords: CIN; Ki67 (MIB-1); p16 INK4a
references: Am J Clin Pathol. 2010 Mar;133(3):395-406
references: 20154278
references: Am J Surg Pathol. 2010 Aug;34(8):1077-87
references: 20661011
references: Gynecol Oncol. 2008 Mar;108(3):598-602
references: 18191996
references: Histopathology. 2007 Apr;50(5):629-35
references: 17394499
references: Int J Gynecol Cancer. 2006 Jan-Feb;16(1):347-53
references: 16445657
references: Am J Surg Pathol. 2002 Nov;26(11):1389-99
references: 12409715
references: Mod Pathol. 2006 Mar;19(3):384-91
references: 16415792
references: Mod Pathol. 2005 May;18(5):629-37
references: 15502810
references: Arch Pathol Lab Med. 2007 Sep;131(9):1343-9
references: 17824788
references: J Gynecol Oncol. 2008 Sep;19(3):162-8
references: 19471565
references: Dis Markers. 2007;23(4):315-30
references: 17627065
references: Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2536-45
references: 18842994
references: Am J Surg Pathol. 2008 Apr;32(4):502-12
references: 18223479
references: Am J Obstet Gynecol. 2009 Nov;201(5):488.e1-7
references: 19683687
references: J Clin Pathol. 2010 Nov;63(11):972-7
references: 20924035
references: Int J Cancer. 2012 Jan 15;130(2):388-94
references: 21387293
references: Am J Surg Pathol. 2001 Jul;25(7):884-91
references: 11420459
references: J Low Genit Tract Dis. 2007 Apr;11(2):98-104
references: 17415114